Skip to content

Dara Manness

NPI 1124798400ActiveIndividual· Nurse Practitioner· West Hartford, CT

Nurse Practitioner in West Hartford, Connecticut, licensed in CT, with an NPI issued in September 2021. Part D covered 1,280 prescriptions written in 2024, 80% of them generic. Neurocrine Biosciences, Inc. reported $114.27 in payments in 2025, mostly food and beverage.

Overview

NPI1124798400
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedSep 17, 2021
Last updated in NPPESAug 6, 2023
Certified by providerAug 6, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Nurse Practitioner (CT)

Part D prescriptions in 2024

Prescriptions (claims)1,280 · 1,283 30-day fills
Patients156
Total drug cost$101,427
Generic share80% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$114.27 · 3 payments from 1 company
  • 2024$282.37 · 6 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Neurocrine Biosciences, Inc.$114.273

What the 2025 payments were for

  • Food and Beverage$114.27 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nurse Practitioner providers in West Hartford

All Nurse Practitioner providers in Connecticut →